Legal & General Group Plc acquired a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 207,482 shares of the company's stock, valued at approximately $6,127,000. Legal & General Group Plc owned 0.22% of Acadia Healthcare at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Acadia Healthcare in the first quarter valued at about $1,600,000. Goldman Sachs Group Inc. increased its position in Acadia Healthcare by 21.1% during the first quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company's stock worth $21,170,000 after acquiring an additional 121,444 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Acadia Healthcare by 8.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company's stock worth $10,337,000 after purchasing an additional 27,207 shares in the last quarter. American Century Companies Inc. boosted its holdings in Acadia Healthcare by 531.5% in the 2nd quarter. American Century Companies Inc. now owns 105,739 shares of the company's stock valued at $2,399,000 after purchasing an additional 88,995 shares during the period. Finally, Prudential Financial Inc. grew its position in shares of Acadia Healthcare by 21.9% during the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company's stock worth $225,000 after purchasing an additional 1,780 shares in the last quarter.
Acadia Healthcare Stock Down 1.8%
Shares of ACHC opened at $27.75 on Thursday. The firm has a 50 day simple moving average of $30.64 and a two-hundred day simple moving average of $26.42. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $35.83. The company has a market cap of $2.58 billion, a P/E ratio of -2.23, a P/E/G ratio of 9.10 and a beta of 0.62.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating analysts' consensus estimates of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. During the same quarter last year, the business posted $0.83 EPS. The company's revenue was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Research analysts forecast that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on the stock. KeyCorp lifted their price target on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an "overweight" rating in a research report on Tuesday, July 14th. Weiss Ratings restated a "sell (d)" rating on shares of Acadia Healthcare in a research note on Friday, June 12th. Jefferies Financial Group raised Acadia Healthcare from a "hold" rating to a "buy" rating and lifted their price objective for the company from $24.50 to $30.00 in a report on Wednesday, June 3rd. UBS Group increased their target price on Acadia Healthcare from $31.00 to $39.00 and gave the stock a "buy" rating in a report on Thursday, July 9th. Finally, Barclays raised their price target on Acadia Healthcare from $25.00 to $32.00 and gave the stock an "equal weight" rating in a research report on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $29.85.
Get Our Latest Stock Report on Acadia Healthcare
Acadia Healthcare Profile
(
Free Report)
Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.
Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.
See Also
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
